Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition

被引:90
作者
Yamamoto, Eiichiro [1 ]
Dong, Yi-Fei [1 ]
Kataoka, Keiichiro [1 ]
Yamashita, Takuro [1 ]
Tokutomi, Yoshiko [1 ]
Matsuba, Shinji [1 ]
Ichijo, Hidenori [3 ]
Ogawa, Hisao [2 ]
Kim-Mitsuyama, Shokei [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto 8608556, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan
关键词
diabetes; obesity; angiotensin; ASK1; reactive oxygen species; vascular endothelial function; cardiac injury;
D O I
10.1161/HYPERTENSIONAHA.108.112292
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Dietary obesity is associated with type 2 diabetes and cardiovascular diseases, although the underlying mechanism is unknown. This study was undertaken to elucidate the role of angiotensin II and apoptosis signal regulating kinase- 1 ( ASK1) in obesity/ diabetes- associated cardiovascular complications and hepatic steatosis. Mice fed a high- fat diet were treated with olmesartan, an angiotensin II type 1 receptor blocker, to elucidate the role of angiotensin II in diabetic mice. Treatment of mice fed a high- fat diet with olmesartan markedly suppressed cardiac inflammation and fibrosis, as well as vascular endothelial dysfunction and remodeling, induced by obesity/ diabetes. Moreover, olmesartan suppressed the disruption of the vascular endothelial NO synthase dimer in diabetic mice. Olmesartan also significantly prevented hepatic steatosis and fibrosis in diabetic mice. These beneficial effects of olmesartan on diabetic mice were associated with the attenuation of ASK1 activation in these mice. ASK1- deficient mice and wild- type mice were compared, regarding the effects of a high- fat diet. A comparison between ASK1- deficient and wild- type mice showed that ASK1 deficiency attenuated cardiac inflammation and fibrosis, as well as vascular endothelial dysfunction and remodeling induced by obesity/ diabetes. The amelioration of vascular endothelial impairment by ASK1 deficiency was attributed to the prevention of endothelial NO synthase dimer disruption. ASK1 deficiency also significantly lessened hepatic steatosis in diabetic mice. In conclusion, our work provided the evidence that ASK1 is significantly activated in diet- induced diabetic mice and contributes to cardiovascular diseases and hepatic steatosis in diabetic mice. Moreover, the beneficial effects of angiotensin II inhibition on dietary diabetic mice seem to be mediated by the inhibition of ASK1 activation.
引用
收藏
页码:573 / 580
页数:8
相关论文
共 38 条
[1]   Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes - A meta-analysis of randomized clinical trials [J].
Abuissa, H ;
Jones, PG ;
Marso, SP ;
O'Keefe, JH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) :821-826
[2]   Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity [J].
Benson, SC ;
Pershadsingh, HA ;
Ho, CI ;
Chittiboyina, A ;
Desai, P ;
Pravenec, M ;
Qi, NN ;
Wang, JM ;
Avery, MA ;
Kurtz, TW .
HYPERTENSION, 2004, 43 (05) :993-1002
[3]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[4]   Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress [J].
Cai, H ;
Harrison, DG .
CIRCULATION RESEARCH, 2000, 87 (10) :840-844
[5]   Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited [J].
Ceriello, A ;
Motz, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) :816-823
[6]   PPAR γ-activating angiotensin type-1 receptor blockers induce adiponectin [J].
Clasen, R ;
Schupp, M ;
Foryst-Ludwig, A ;
Sprang, C ;
Clemenz, M ;
Krikov, M ;
Thöne-Reineke, C ;
Unger, T ;
Kintscher, U .
HYPERTENSION, 2005, 46 (01) :137-143
[7]   Endothelial nitric oxide synthase in vascular disease -: From marvel to menace [J].
Förstermann, U ;
Münzel, T .
CIRCULATION, 2006, 113 (13) :1708-1714
[8]   Increased oxidative stress in obesity and its impact on metabolic syndrome [J].
Furukawa, S ;
Fujita, T ;
Shimabukuro, M ;
Iwaki, M ;
Yamada, Y ;
Nakajima, Y ;
Nakayama, O ;
Makishima, M ;
Matsuda, M ;
Shimomura, I .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1752-1761
[9]  
Hink U, 2001, CIRC RES, V88, pE14
[10]   Adiposity as compared with physical activity in predicting mortality among women [J].
Hu, FB ;
Willett, WC ;
Li, T ;
Stampfer, MJ ;
Colditz, GA ;
Manson, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (26) :2694-2703